The collaboration will explore RNA-based small molecule drug candidates aimed at neurological conditions where existing ...

The global biotherapeutics company announced that it will seek to streamline operations as part of a broader transformation ...

Whole genome sequencing market is projected to grow significantly, driven by advancements in technology and personalized ...

Recent advancements in COPD treatments are providing patients with potential new first-line treatments. Pharmaceutical ...

Vanda Pharmaceuticals won a legal battle as a federal court overturned the FDA's rejection of Hetlioz for jet lag disorder, ...

Tonmya is the first new fibromyalgia therapy approved in over 15 years, targeting nonrestorative sleep to alleviate core ...

Novo Nordisk reduces Ozempic's price to $499/month for self-paying patients, enhancing access to essential diabetes treatment ...

NIH's new strategy emphasizes transparency, prioritizes urgent health needs, and shifts focus to domestic research and ...

Rob Abbott, CEO, ISPOR, highlights that the United States excels in areas like cancer screening and advanced medical ...

Expanded approval of Wegovy was based on results from the Phase III ESSENCE trial (NCT04822181), which demonstrated ...

What is MFN in pharma? President Trump’s executive order on drug pricing states that the United States should be treated as a ...

An examination of proactive preparedness and readiness review for future enrollment in the agency’s QMM program—now in the ...